Case report: Alectinib-associated intestinal ulceration and colitis in a patient with non-small cell lung cancer and effective treatment with Mesalazine. [PDF]
Pathol Oncol ResQiu Z, Ke F, Zhu X.
europepmc +1 more source
Incentivizing Postmarketing Pharmaceutical Product Safety Testing with Extension of Exclusivity Periods [PDF]
, 2008 Kushner, Leslie
core +1 more source
FDA approval of Amivantamab-Vmjw in combination with carboplatin and pemetrexed for EGFR-mutated NSCLC: a new therapeutic milestone. [PDF]
Ann Med Surg (Lond)Hassan IN, Ibrahim MNH.
europepmc +1 more source
Efficacy and safety of lacosamide in patients with trigeminal neuralgia: an 8-week pilot dose-escalation study. [PDF]
J Oral Facial Pain HeadacheLappichetpaiboon P +5 more
europepmc +1 more source
Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data. [PDF]
BMC Pharmacol ToxicolTu J +6 more
europepmc +1 more source
A real-world disproportionality analysis of ripretinib data mining of the public version of FDA adverse event reporting system. [PDF]
Front PharmacolFeng Y +5 more
europepmc +1 more source
Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems. [PDF]
Clin Exp MedAljabri A +4 more
europepmc +1 more source
Multidimensional assessment of adverse events of finasterideļ¼a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024. [PDF]
PLoS OneZhong X, Yang Y, Wei S, Liu Y.
europepmc +1 more source
A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database. [PDF]
Sci RepSong Y +5 more
europepmc +1 more source